We are a law firm dedicated to helping those injured by Medtronic Sprint Fidelis Defibrillator Lead.
Medtronic Recall Lawsuit
The Medtronic class action lawsuits are being handled through what is called multidistrict litigation or “MDL”. Lawsuits involving thousands or tens of thousands of people are frequently referred to as class actions, however they are often in the form of multidistrict litigation.
All of the Medtronic recall cases have been consolidated and transferred to federal court in Minnesota where Medtronic is headquartered. Cases are still pursued individually. This means that individuals affected by the Medtronic defective leads recall maintain control over their case. Multidistrict litigation typically only involves discovery matters and cases are returned to the original court in which they were filed after the completion of the discovery stage of the Medtronic litigation.
There is not one trial that involves all of the cases. Multidistrict litigation only pertains to the discovery part of the Medtronic lawsuit. Our Medtronic class action lead recall attorneys are reviewing individual cases and working with clients throughout the United States. If you would like to discuss your case with a Medtronic lead recall attorney we are ready to help answer your questions. Please call us for a free consultation toll free at 1-888-343-5375 or 1-612-370-1511 or you can also send us an e-mail using our contact form on this page.
U.S. Food & Drug Administration Statement On Medtronic Sprint Fidelis Defibrillator
Medtronic Suspends Sprint Fidelis Defibrillation Leads (PDF)
U.S. FDA Class 1 Recall Report
If you or a loved one have been injured by the Medtronic Sprint Fidelis lead please contact us immediately. You may be entitled to compensation.
Following the Medtronic recall of their Sprint Fidelis leads the Food and Drug Administration (FDA) has been involved keeping patients informed of new information regarding the defective leads as it becomes available. The following Question and Answer sheet was released by the FDA to help consumers affected by the Medtronic lead recall.
Medtronic Recalls Sprint Fidelis […]
On June 11, 2008 Bridget Robb testified before the Senate Judiciary Committee regarding her experience with the Medtronic lead recall. Ms. Robb suffered 31 shocks as a result of a defective Sprint Fidelis lead manufactured by Medtronic. Ms. Robb tells her story and shows how important it is for manufacturers of dangerous and defective products to […]
Following the Medtronic recall of their Sprint Fidelis heart leads the FDA released a statement covering the background of the Medtronic leads and recommendations.
Neither the FDA, Medtronic, nor representatives of the Heart Rhythm Society, recommend the routine surgical removal of a fractured lead because removal carries risks. Instead, physicians should weigh the benefits and risks […]
On October 15, 2007, Medtronic, Inc. announced that it was recalling its Sprint Fidelis defibrillation leads. Medtronic announced that the recall was due to “the potential for lead fractures.” At the time of the recall, there were reports of at least five deaths associated with the defibrillator leads. The Food and Drug Administration classified the […]
As of October 2007, Medtronic was aware of at least 665 chronic fractures in returned Sprint Fidelis leads. The majority of these fractures (approximately 90%) have occurred in the anode or cathode conductors. The Medtronic Sprint Fidelis 6930 lead was included in the 2007 recall. There seems to be evidence that Medtronic has knowledge their […]